Invention Grant
US07696313B2 Prodrug compounds with isoleucine 有权
前药与异亮氨酸的化合物

Prodrug compounds with isoleucine
Abstract:
The compounds of the invention are modified forms of therapeutic agents. A typical prodrug compound of the invention comprises a therapeutic agent, an oligopeptide having an isoleucine residue, a stabilizing group and, optionally, a linker group. The prodrug is cleavable by an enzyme associated with the target cell. Methods of making and using the compounds are also disclosed.
Public/Granted literature
Information query
Patent Agency Ranking
0/0